Retinal degeneration in a mouse model of CRB1 disease rescued by the photoreceptor-specific CRB1-B isoform
Many genes involved in inherited diseases produce alternate mRNA isoforms that remain poorly characterized. Functional assessment of these isoforms could therefore unlock new insights into disease pathobiology or treatment. Here we investigated the function of the newly discovered B isoform of CRB1, a gene implicated in inherited retinal degenerations. CRB1-B is the most abundant retinal isoform,…
A recent study has explored the role of a newly discovered isoform of the CRB1 gene in inherited retinal degenerations. CRB1-B, the most abundant photoreceptor-specific isoform, was found to have a significant impact on preventing disease progression and restoring visual function in a mouse model. By restoring CRB1-B expression in photoreceptors, researchers were able to preserve adherens junctions between photoreceptors and supporting glia, thus halting the progressive loss of these critical connections.
This therapeutic mechanism suggests that targeting the CRB1-B isoform could serve as a promising gene therapy strategy for treating inherited retinal degenerations. The broader implications of this research highlight the potential value of investigating the diverse isoforms produced by disease genes as a means to develop novel therapeutic approaches.
Written by urgent.news from bioRxiv's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
